Characterisation of Cancer Stem Cell Populations in Primary Glioblastoma Cultures: A Review

Abstract

Background: Glioblastoma contains cells that initiate tumours at low dose and resist therapy. How that population should be
defined, and whether it is a fixed compartment, remains contested.
Objective: To review how cancer stem cell populations are characterised in primary glioblastoma culture, and what the
markers and assays establish.
Methods: Narrative review of primary studies on glioma stem cell isolation, culture conditions, marker validation, functional
assays and heterogeneity.
Findings: As few as 100 CD133-positive cells initiated a serially transplantable tumour where 100,000 negative cells did not,
but stem-like CD133-negative cells were later shown to sustain a subset of tumours, so the marker is neither necessary nor
sufficient. Serum-cultured lines diverge from the parent tumour, while serum-free bFGF and EGF culture preserves genotype
and phenotype. Single-cell sequencing describes four interconverting states rather than fixed types.
Conclusions: Functional assays, not surface markers, define the population, and plasticity makes that definition conditional.